A retrospective single center study of efficacy and safety of secukinumab treatment in patients with ankylosing spondylitis
Latest Information Update: 16 Feb 2021
At a glance
- Drugs Secukinumab (Primary)
- Indications Ankylosing spondylitis
- Focus Adverse reactions; Therapeutic Use
- 16 Feb 2021 New trial record